Diffuse pruritic erythema as a clinical manifestation in anti-SAE antibody-associated dermatomyositis: a case report and literature review
| Autor: | Yanying Zhang, Xia Qiu, Yubao Jiang, Ertao Jia, Jianyong Zhang, Li Zhong, Min Xiao, Yuya Xiao, Jiaxin Wei, Hongling Geng, Jingjing Xie |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
Erythema Prednisolone Ubiquitin-Activating Enzymes Malignancy Antibodies Dermatomyositis 03 medical and health sciences 0302 clinical medicine Rheumatology Asian People Internal medicine medicine Humans 030212 general & internal medicine 030203 arthritis & rheumatology business.industry Pruritus Interstitial lung disease General Medicine Middle Aged medicine.disease Dermatology Thalidomide Methotrexate Treatment Outcome Cohort Cyclosporine Female medicine.symptom business medicine.drug |
| Zdroj: | Clinical rheumatology. 38(8) |
| ISSN: | 1434-9949 |
| Popis: | Anti-small ubiquitin-like modifier-1 activating enzyme (anti-SAE) antibodies have been recently discovered especially for myosin and identified as dermatomyositis (DM) marker. The frequency of anti-SAE antibodies in DM patients is extremely low. Diffuse pruritic erythema may be one kind of clinical manifestations of DM with anti-SAE antibodies. In this report, a 48-year-old female patient with amyopathic dermatomyositis (ADM) carrying anti-SAE antibodies presented diffuse pruritic erythema for 5 months. Diffuse pruritic erythema improved after treatment with prednisolone, cyclosporine, and thalidomide. The clinical characteristics of 75 previously reported cases with anti-SAE antibody-positive DM were reviewed, and the manifestations of the Asian and Western cohorts were compared. It was revealed that the Asian patients were more susceptible to diffuse erythema (17/34 vs. 3/41, P = 0.000), dysphagia (16/34 vs. 10/41, P = 0.040), and interstitial lung disease (ILD) (21/34 vs. 5/41, P = 0.000) compared with the Western patients. The frequency of malignancy in the Asian cohort was significantly higher than that in the Western cohort (10/34 vs. 4/41, P = 0.030). |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink